3-Year Safety Profile of Belatacept in Kidney Transplant Recipients from the BENEFIT and BENEFIT-EXT Studies

被引：0
|
作者：
Larsen, C. [1 ]
Grinyo, J. [2 ]
Pestana, J. M. [3 ]
Vanrenterghem, Y. [4 ]
Vincenti, F. [5 ]
Dong, Y. [6 ]
Thomas, D. [6 ]
Charpentier, B. [7 ]
机构：
[1] Emory Univ, Transplant Ctr, Atlanta, GA 30322 USA
[2] Univ Hosp Bellvitge, Barcelona, Spain
[3] Hosp Rim & Hipertensao, Sao Paulo, Brazil
[4] Katholieke Univ Leuven Hosp, Louvain, Belgium
[5] UCSF Kidney Transplant Serv, San Francisco, CA USA
[6] Bristol Myers Squibb Co, Princeton, NJ USA
[7] Hop Bicetre, Le Kremlin Bicetre, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
228
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [31] Three-Year Outcomes in Elderly Kidney Transplant Recipients Treated with Belatacept vs Cyclosporine in BENEFIT-EXT.
    Rice, K.
    Vanrenterghem, Y.
    Merville, P.
    Muehlbacher, F.
    Zhang, R.
    Duan, T.
    Thomas, D.
    Charpentier, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 403 - 403
  • [32] EVALUATION OF DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT PATIENTS TREATED WITH BELATACEPT- OR CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN BENEFIT AND BENEFIT-EXT
    Larsen, Christian P.
    Bray, Robert
    Gebel, Howard
    Ganguly, Bishu
    Kulbokas, Ej
    Brickman, Daniel
    Duan, Tao
    Townsend, Robert
    TRANSPLANT INTERNATIONAL, 2011, 24 : 69 - 69
  • [33] The External Validation of the Cardiovascular Risk Equation for Renal Transplant Recipients: Applications to BENEFIT and BENEFIT-EXT Trials
    Soveri, Inga
    Snyder, Jon
    Holdaas, Hallvard
    Holme, Ingar
    Jardine, Alan G.
    L'Italien, Gilbert J.
    Fellstrom, Bengt
    TRANSPLANTATION, 2013, 95 (01) : 142 - 147
  • [34] 4-Year Results from the Long-Term Extension of the Belatacept BENEFIT-EXT Study
    Florman, S.
    Durrbach, A.
    Grinyo, J.
    Pestana, J. O. M.
    Rial, M. d. C.
    Vitko, S.
    Lin, C. -S.
    Harler, M. B.
    Rostaing, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 82 - 82
  • [35] Final Results from the BENEFIT-EXT Trial: A 7 Year Follow-Up of Belatacept Treated Patients
    Florman, S.
    Pestana, J. Medina
    Rial, M.
    Rostaing, L.
    Kuypers, D.
    Muehlbacher, F.
    Polinsky, M.
    Meier-Kriesche, U.
    Grinyo, J.
    Durrbach, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [36] Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys
    Pestana, J. O. M.
    Grinyo, J. M.
    Vanrenterghem, Y.
    Becker, T.
    Campistol, J. M.
    Florman, S.
    Garcia, V. D.
    Kamar, N.
    Lang, P.
    Manfro, R. C.
    Massari, P.
    Rial, M. D. C.
    Schnitzler, M. A.
    Vitko, S.
    Duan, T.
    Block, A.
    Harler, M. B.
    Durrbach, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) : 630 - 639
  • [37] De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies
    Bray, R. A.
    Gebel, H. M.
    Townsend, R.
    Roberts, M. E.
    Polinsky, M.
    Yang, L.
    Meier-Kriesche, H. -U.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (07) : 1783 - 1789
  • [38] BENEFIT-EXT STUDY TWO YEAR OUTCOMES: BELATACEPT VS CYCLOSPORINE (CSA) IN EXTENDED CRITERIA DONOR (ECD) KIDNEY TRANSPLANTS
    Russ, G.
    Durrbach, A.
    Larsen, C. P.
    Pestana, Medina J.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Xing, J.
    Block, A.
    Garg, P.
    Christina, Xinos
    Grinyo, J.
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (07): : A2 - A2
  • [39] Belatacept vs Cyclosporine in Kidney Transplant Recipients: Two-Year Outcomes from the BENEFIT Study
    Larsen, C. P.
    Grinyo, J.
    Charpentier, B.
    Pestana, J. Medina
    Kamar, N.
    Vanrenterghem, Y.
    Lin, C. -S.
    Di Russo, G.
    Garg, P.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 82 - 82
  • [40] BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY
    Larsen, C.
    Grinyo, J.
    Charpentier, B.
    Medina Pestana, J.
    Kamar, N.
    Vanrenterghem, Y.
    Lin, C.
    Di Russo, G.
    Garg, P.
    Vincenti, F.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 59 - 59
12345